Povidone Iodine Solution Franchise in Ahmedabad

Antiseptic Solution Supplier in Mumbai

Wound Care Antiseptic Distributor in Delhi

Infection Control Pharma Franchise in Bangalore

Povidone Iodine Solution Stockist in Hyderabad
Antiseptic & Wound Care Solution Manufacturer & Exporter in Chandigarh

Home/Products /povidone-iodine-10-w-v-ointment

Povidyle Solution

Composition : Povidone Iodine (10% w/v) Solution

Dosage Form : Ointment

Packaging Type : Bottle

Packaging : 100ml

Price : ₹0/-

Please Contact For Best Price

Povidyle Solution contains Povidone Iodine 10% w/v, a trusted antiseptic solution used for effective disinfection of wounds, cuts, burns, and surgical sites. It works by releasing iodine gradually, providing rapid and long-lasting antimicrobial action.

This solution is widely used in hospitals, clinics, and primary care settings for preoperative skin preparation, wound cleansing, and infection prevention, ensuring reliable protection against a broad range of pathogens.

For franchise partners, Povidyle Solution is a high-rotation antiseptic product with consistent demand across surgical, emergency, and general care segments. Its routine clinical use supports steady secondary sales and portfolio strength.

With continuous need for infection control and wound management, Povidyle Solution offers stable and scalable business opportunities, helping partners expand their presence in the antiseptic and wound care therapy segment.

Read More

About the Product

Povidyle Solution contains Povidone Iodine 10% w/v, a trusted antiseptic solution used for effective disinfection of wounds, cuts, burns, and surgical sites. It works by releasing iodine gradually, providing rapid and long-lasting antimicrobial action.

This solution is widely used in hospitals, clinics, and primary care settings for preoperative skin preparation, wound cleansing, and infection prevention, ensuring reliable protection against a broad range of pathogens.

For franchise partners, Povidyle Solution is a high-rotation antiseptic product with consistent demand across surgical, emergency, and general care segments. Its routine clinical use supports steady secondary sales and portfolio strength.

With continuous need for infection control and wound management, Povidyle Solution offers stable and scalable business opportunities, helping partners expand their presence in the antiseptic and wound care therapy segment.

Generally well tolerated, but some individuals may experience mild skin irritation, redness, itching, or a burning sensation at the application site. Prolonged or excessive use may rarely cause allergic reactions or skin sensitivity. Discontinue use and consult a healthcare professional if severe irritation occurs.

Povidyle Solution is indicated for the prevention and treatment of infections in cuts, wounds, burns, ulcers, and abrasions. It is also used for pre-operative skin preparation, post-operative wound care, and general skin disinfection in medical and surgical settings.

Povidyle Solution is for external use only. Avoid contact with eyes and do not use on large areas of skin for prolonged periods without medical advice. Use with caution in patients with iodine sensitivity, thyroid disorders, or in pregnant and breastfeeding women unless advised by a doctor.

Store Povidyle Solution in a cool, dry place below 25°C, protected from direct sunlight. Keep the container tightly closed and out of reach of children. Do not use after the expiry date mentioned on the bottle.

Get in Touch

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our Successful network today.

Quick Navigation

1500+ Products

Our Divisions

All Therapeutics

Disclaimer: Pharma Insights are based on operational standards as of March 2026. All territories are subject to availability and Revised Schedule M compliance.